Reply to: MIDN locus structural variants and Parkinsonâs disease risk
- 期刊名称Annals of Clinical and Translational Neurology
- 作者Obara, Yutaro; Sato, Hidenori; Nakayama, Takahiro; Kato, Takeo; Ishii, Kuniaki
- 印刷ISSN2328-9503
- 文件大小70.03KB
- 发表时间2020-03-22
- DOI10.1002/acn3.51011
Biomedical Applications of GrapheneShen, He; Zhang, Liming; Liu, Min; Zhang, Zhijun · Theranostics · 2012
Protease Activity: Meeting Its Theranostic PotentialLee, Seulki; Kim, Kwangmeyung · Theranostics · 2012
Nano-Carbons as TheranosticsLiu, Zhuang; Liang, Xing-Jie · Theranostics · 2012
Applications of Magnetic Microbubbles for TheranosticsCai, Xiaowei; Yang, Fang; Gu, Ning · Theranostics · 2012
Protease-Activated Drug DevelopmentChoi, Ki Young; Swierczewska, Magdalena; Lee, Seulki; Chen, Xiaoyuan · Theranostics · 2012
Porphyrins and Phthalocyanines for TheranosticsLovell, Jonathan F.; Lo, Pui-Chi · Theranostics · 2012
PET Imaging of Inflammation BiomarkersWu, Chenxi; Li, Fang; Niu, Gang; Chen, Xiaoyuan · Theranostics · 2013
Proton Therapy Verification with PET ImagingZhu, Xuping; Fakhri, Georges El · Theranostics · 2013